NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Ownership - Who owns Quoin Pharmaceuticals?

Insider buying vs selling

Have Quoin Pharmaceuticals Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Denise P. CarterChief Operating Officer2024-12-23555,556$0.45
$250.00kBuy
Michael MyersChief Executive Officer2024-12-23555,556$0.45
$250.00kBuy
Gordon DunnChief Financial Officer2024-12-23122,221$0.45
$55.00kBuy
Anthony James CulverwellDirector2024-12-23100,000$0.45
$45.00kBuy
Gordon DunnChief Financial Officer2024-09-1010,000$0.71
$7.10kBuy
Gordon DunnChief Financial Officer2024-09-1010,000$0.91
$9.10kBuy
Gordon DunnChief Financial Officer2024-09-094,000$0.80
$3.20kBuy
Gordon DunnChief Financial Officer2024-09-094,000$0.78
$3.12kBuy
Gordon DunnChief Financial Officer2024-09-09856$0.80
$684.80Buy
Denise P. CarterChief Operating Officer2024-09-048,825$0.75
$6.60kBuy

1 of 2

QNRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QNRX insiders and whales buy or sell their stock.

QNRX Shareholders

What type of owners hold Quoin Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael Myers2.93%602,808$3.97MInsider
Denise P. Carter2.93%602,648$3.97MInsider
Armistice Capital LLC2.57%530,000$3.49MInstitution
Altium Capital Management LLC1.37%282,249$1.86MInstitution
Ikarian Capital LLC1.34%275,000$1.81MInstitution
Gordon Dunn0.73%151,077$994.09kInsider
Renaissance Technologies LLC0.65%133,122$875.94kInstitution
Anthony James Culverwell0.49%100,317$660.09kInsider
Boothbay Fund Management LLC0.39%80,712$531.08kInstitution
Apollon Wealth Management LLC0.39%80,025$526.56kInstitution

1 of 3

QNRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNRX7.51%7.08%Net Buying
INDP4.42%50.94%Net Buying
GNPX1.21%21.13%Net SellingNet Selling
MTVA3.18%96.82%Net BuyingNet Selling
CTXR5.22%94.78%

Quoin Pharmaceuticals Stock Ownership FAQ

Who owns Quoin Pharmaceuticals?

Quoin Pharmaceuticals (NASDAQ: QNRX) is owned by 7.51% institutional shareholders, 7.08% Quoin Pharmaceuticals insiders, and 85.41% retail investors. Michael Myers is the largest individual Quoin Pharmaceuticals shareholder, owning 602,808.00 shares representing 2.93% of the company. Michael Myers's Quoin Pharmaceuticals shares are currently valued at $3.97M.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.